173 related articles for article (PubMed ID: 21779833)
1. Urothelial carcinoma.
Merseburger AS; Shariat SF
World J Urol; 2011 Aug; 29(4):405-7. PubMed ID: 21779833
[No Abstract] [Full Text] [Related]
2. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F; Chebil G; Månsson W
Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer.
Clark PE; Agarwal N; Biagioli MC; Eisenberger MA; Greenberg RE; Herr HW; Inman BA; Kuban DA; Kuzel TM; Lele SM; Michalski J; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Porter MP; Richie JP; Sexton WJ; Shipley WU; Small EJ; Spiess PE; Trump DL; Wile G; Wilson TG; Dwyer M; Ho M;
J Natl Compr Canc Netw; 2013 Apr; 11(4):446-75. PubMed ID: 23584347
[TBL] [Abstract][Full Text] [Related]
4. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.
Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J; Rouprêt M;
Eur Urol; 2011 Jun; 59(6):997-1008. PubMed ID: 21458150
[TBL] [Abstract][Full Text] [Related]
5. Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.
Klaassen Z; Kamat AM; Kassouf W; Gontero P; Villavicencio H; Bellmunt J; van Rhijn BWG; Hartmann A; Catto JWF; Kulkarni GS
Eur Urol; 2018 Nov; 74(5):597-608. PubMed ID: 30017405
[TBL] [Abstract][Full Text] [Related]
6. [Recommendations Onco-Urology 2010: Urothelial tumors].
Pfister C; Roupret M; Wallerand H; Davin JL; Quintens H; Guy L; Houede N; Bernardini S; Larré S; Mazerolles C; Roy C; Amsellem D; Saint F; Irani J; Soulié M;
Prog Urol; 2010 Nov; 20 Suppl 4():S255-74. PubMed ID: 21129645
[No Abstract] [Full Text] [Related]
7. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Sharma P; Bajorin DF; Jungbluth AA; Herr H; Old LJ; Gnjatic S
J Immunother; 2008; 31(9):849-57. PubMed ID: 18833002
[TBL] [Abstract][Full Text] [Related]
8. [Urothelial tumors of the upper urinary tract].
Boissier R; Bastien L; Lechevallier É; Meria P
Rev Prat; 2014 Dec; 64(10):1408-10, 1412-4. PubMed ID: 25665325
[No Abstract] [Full Text] [Related]
9. Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma.
DiBianco JM; George AK; Su D; Agarwal PK
Curr Opin Urol; 2015 Sep; 25(5):468-75. PubMed ID: 26125507
[TBL] [Abstract][Full Text] [Related]
10. Bladder Tumor Subtype Commitment Occurs in Carcinoma
Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
[TBL] [Abstract][Full Text] [Related]
11. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
[TBL] [Abstract][Full Text] [Related]
13. What happens if nothing happens?--History of an untreated urothelial carcinoma of the bladder.
Gerullis H; Ecke TH; Wishahi M; Georgas E; Eimer C; Otto T
J Egypt Soc Parasitol; 2010 Dec; 40(3):789-96. PubMed ID: 21268545
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of urothelial carcinoma.
Miyazaki J; Nishiyama H
Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
[TBL] [Abstract][Full Text] [Related]
15. Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer.
Zaghloul MS; Gouda I
Expert Rev Anticancer Ther; 2012 Jun; 12(6):753-63. PubMed ID: 22716492
[TBL] [Abstract][Full Text] [Related]
16. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
17. Malignant lymphoma case with urinary cytology mimicking that of urothelial carcinoma.
Takahashi H; Shimazaki H; Oda T; Endo H; Sekitsuka H; Maekawa K; Katsurada Y; Sato K; Ito K; Nakanishi K; Tamai S
Cytopathology; 2013 Dec; 24(6):412-4. PubMed ID: 23078009
[No Abstract] [Full Text] [Related]
18. ICUD-EAU International Consultation on Bladder Cancer 2012: Urothelial carcinoma of the prostate.
Palou J; Wood D; Bochner BH; van der Poel H; Al-Ahmadie HA; Yossepowitch O; Soloway MS; Jenkins LC;
Eur Urol; 2013 Jan; 63(1):81-7. PubMed ID: 22938869
[TBL] [Abstract][Full Text] [Related]
19. Targeting Hsp90 in urothelial carcinoma.
Chehab M; Caza T; Skotnicki K; Landas S; Bratslavsky G; Mollapour M; Bourboulia D
Oncotarget; 2015 Apr; 6(11):8454-73. PubMed ID: 25909217
[TBL] [Abstract][Full Text] [Related]
20. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ
Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
